Tolerability and efficacy of ropinirole in patients with intermittent restless legs syndrome (RLS): Open-label results

被引：0
|
作者：
Black, J.
Merchant, K.
机构：
[1] GlaxoSmithKline Inc, Res Triangle Pk, NC USA
[2] Stanford Univ, Stanford, CA 94305 USA
来源：
MOVEMENT DISORDERS | 2006年 / 21卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：1554 / 1554
页数：1
相关论文
共 50 条
  • [41] Open-label study of the long-term efficacy and safety of pramipexole in patients with Restless Legs Syndrome (extension of the PRELUDE study)
    Partinen, Markku
    Hirvonen, Kari
    Jama, Leni
    Alakuijala, Anniina
    Hublin, Christer
    Tamminen, Ilkka
    Koester, Juergen
    Reess, Juergen
    SLEEP MEDICINE, 2008, 9 (05) : 537 - 541
  • [42] Efficacy of dopamine agonists in the management of restless legs syndrome (RLS)
    Ferini-Strambi, L.
    EUROPEAN JOURNAL OF NEUROLOGY, 2006, 13 : 320 - 320
  • [43] Cytokine levels in patients with restless legs syndrome (RLS)
    Siddiqui, F
    Strus, J
    Silveira, D
    Sun, YM
    Chokroverty, S
    Walters, A
    NEUROLOGY, 2006, 66 (05) : A77 - A77
  • [44] Role of cytokines in patients with Restless Legs Syndrome(RLS)
    Siddiqui, F.
    Strus, J.
    Silveria, D. C.
    Sun, Y. J.
    Chokroverty, S.
    Walters, A. S.
    SLEEP, 2006, 29 : A283 - A283
  • [45] Ropinirole improves mood and symptoms of anxiety and depression in patients with Restless Legs Syndrome (RLS) requiring extended treatment
    Schmidt, M. H.
    Becker, P. M.
    Tolson, J. M.
    SLEEP, 2006, 29 : A278 - A278
  • [46] Ropinirole (REQUIP®) provides symptom relief in patients with Restless Legs Syndrome (RLS) regardless of family history.
    Ziman, Ronald B.
    Hosford, David A.
    ARTHRITIS AND RHEUMATISM, 2006, 54 (09): : S145 - S146
  • [47] Improvements in symptom-related sleep disturbance during ropinirole treatment in patients with Restless Legs Syndrome (RLS)
    Kushida, C. A.
    Earl, N. L.
    SLEEP, 2006, 29 : A280 - A281
  • [48] Ropinirole reduces severity of restless legs syndrome (RLS) in patients with symptom onset in the late afternoon/early evening
    Geyer, J.
    Earl, N.
    Tolson, J.
    MOVEMENT DISORDERS, 2006, 21 : S433 - S433
  • [49] Controlled withdrawal of pramipexole after 6 months of open-label treatment in patients with restless legs syndrome
    Trenkwalder, Claudia
    Stiasny-Kolster, Karin
    Kupsch, Andreas
    Oertel, Wolfgang H.
    Koester, Juergen
    Reess, Juergen
    MOVEMENT DISORDERS, 2006, 21 (09) : 1404 - 1410
  • [50] Ropinirole reduces sleep disturbance in patients with restless legs syndrome
    Dreykluft, T.
    Earl, N. L.
    JOURNAL OF SLEEP RESEARCH, 2006, 15 : 88 - 88
12345